Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

LBPH

Longboard Pharmaceuticals (LBPH)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LBPH
DataOraFonteTitoloSimboloCompagnia
24/05/202422:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LBPHLongboard Pharmaceuticals Inc
24/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
06/05/202422:01Business WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/05/202422:01Business WireLongboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/04/202415:00Business WireLongboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15NASDAQ:LBPHLongboard Pharmaceuticals Inc
12/03/202421:01Business WireLongboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/02/202414:30Business WireLongboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in FebruaryNASDAQ:LBPHLongboard Pharmaceuticals Inc
08/01/202422:05Business WireLongboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/01/202422:48Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
04/01/202403:40Business WireLongboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common StockNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/01/202402:59Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/01/202422:01Business WireLongboard Pharmaceuticals Announces Commencement of Public Offering of Common StockNASDAQ:LBPHLongboard Pharmaceuticals Inc
02/01/202414:00Business WireLongboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)NASDAQ:LBPHLongboard Pharmaceuticals Inc
01/01/202422:47Business WireLongboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)NASDAQ:LBPHLongboard Pharmaceuticals Inc
29/11/202314:30Business WireLongboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy VolunteersNASDAQ:LBPHLongboard Pharmaceuticals Inc
21/11/202322:00Business WireLongboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy CommunityNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/11/202321:01Business WireLongboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/11/202321:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/11/202321:01Business WireLongboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/11/202313:30Business WireLongboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in NovemberNASDAQ:LBPHLongboard Pharmaceuticals Inc
05/10/202322:05Business WireLongboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023NASDAQ:LBPHLongboard Pharmaceuticals Inc
19/09/202314:30Business WireLongboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023NASDAQ:LBPHLongboard Pharmaceuticals Inc
31/08/202322:00Business WireLongboard Pharmaceuticals to Participate in Three Upcoming Investor ConferencesNASDAQ:LBPHLongboard Pharmaceuticals Inc
30/08/202322:01Business WireLongboard Pharmaceuticals to Present Data at Upcoming Medical MeetingsNASDAQ:LBPHLongboard Pharmaceuticals Inc
23/08/202314:30Business WireLongboard Pharmaceuticals Completes Enrollment of Phase 1b/2a PACIFIC Study Evaluating LP352 for the Treatment of Developmental and Epileptic EncephalopathiesNASDAQ:LBPHLongboard Pharmaceuticals Inc
14/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/08/202322:10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/08/202322:01Business WireLongboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/08/202314:30Business WireLongboard Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:LBPHLongboard Pharmaceuticals Inc
26/06/202322:00Business WireLongboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023NASDAQ:LBPHLongboard Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LBPH
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network